|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.49 USD | -2.62% |
|
+1.19% | -20.89% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.62% | +1.19% | +10.10% | +11.81% | -20.89% | +18.54% | +68.49% | +59.89% | +193.04% | 1.22B | |
| +2.99% | +3.09% | +7.60% | +32.81% | +15.06% | +59.99% | +173.52% | +424.36% | +1,458.93% | 1,070B | |
| +3.34% | +5.63% | +15.55% | +12.52% | +29.63% | +72.78% | +68.46% | +58.36% | +118.98% | 624B | |
| -0.23% | +1.43% | +14.43% | +23.69% | +11.71% | +36.04% | +88.38% | +118.63% | +302.41% | 450B | |
| +2.14% | -2.07% | +1.44% | +4.34% | +1.10% | +27.62% | +22.57% | -6.14% | +31.98% | 328B | |
| +1.87% | +1.87% | +4.12% | -3.97% | +4.16% | +40.58% | +42.08% | +65.90% | +212.70% | 292B | |
| +1.36% | +0.17% | +8.06% | +5.84% | +15.69% | +29.90% | +49.33% | +49.23% | +58.40% | 284B | |
| +1.98% | +4.08% | +20.39% | +39.28% | +0.68% | -25.78% | -39.02% | +20.99% | +79.03% | 217B | |
| +0.31% | +1.97% | +6.80% | +8.60% | +12.82% | +26.05% | +68.88% | +51.82% | +135.81% | 198B | |
| +4.44% | +7.68% | +6.20% | -1.98% | +10.84% | +21.71% | +82.81% | +99.01% | +59.17% | 161B | |
| +1.43% | +0.06% | -5.95% | -11.09% | -3.23% | -4.54% | -32.18% | -38.77% | -32.64% | 135B | |
| -1.21% | +5.42% | +18.22% | +21.26% | +15.51% | +13.99% | +54.85% | +163.16% | +481.53% | 134B | |
| +3.39% | +0.82% | +4.54% | +0.74% | +7.70% | +24.96% | -7.27% | -13.47% | -21.58% | 116B | |
| +1.01% | +1.11% | +4.70% | -4.44% | +9.78% | +43.53% | +52.20% | +11.51% | -3.35% | 106B | |
| +1.70% | +0.93% | -1.16% | -5.88% | -8.39% | -8.08% | -19.34% | -12.70% | +2.35% | 102B | |
| +1.05% | +0.61% | +0.87% | -14.04% | -7.56% | +6.95% | +96.34% | +78.12% | +523.74% | 76.45B | |
| -0.70% | +4.98% | +42.39% | +29.41% | +37.31% | +94.34% | +4.22% | -0.29% | -42.65% | 57.41B | |
| -2.48% | +4.59% | +17.59% | -1.81% | -7.07% | +3.94% | +15.07% | -10.80% | +265.50% | 55.16B | |
| -1.25% | +5.26% | +10.60% | -5.32% | +12.68% | +22.70% | +21.26% | +47.32% | +24.27% | 53.69B | |
| +1.92% | +5.09% | +10.39% | -1.03% | -2.51% | -1.59% | +18.33% | - | - | 42.21B | |
| Average | +1.08% | +2.08% | +9.84% | +7.04% | +6.75% | +25.18% | +41.45% | +61.38% | +202.51% | 225.18B | |
| Weighted average by Cap. | +2.00% | +1.08% | +9.35% | +14.65% | +12.16% | +38.54% | +74.73% | +140.97% | +454.09% |
- Stock Market
- Stocks
- COLL Stock
- Sector Collegium Pharmaceutical, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
